BioLineRx Ltd. (TLV: BLRX)
Israel
· Delayed Price · Currency is ILS · Price in ILA17.00
+0.20 (1.19%)
Sep 12, 2024, 4:12 PM IDT
BioLineRx Revenue
BioLineRx had revenue of $5.39M USD in the quarter ending June 30, 2024. This brings the company's revenue in the last twelve months to $17.05M. In the year 2023, BioLineRx had annual revenue of $4.80M.
Revenue (ttm)
$17.05M
Revenue Growth
n/a
P/S Ratio
2.84
Revenue / Employee
$215.80K
Employees
79
Market Cap
203.96M ILS
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBioLineRx News
- 4 weeks ago - BioLineRx Ltd. (BLRX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - BioLineRx GAAP EPS of $0.00, revenue of $5.39M - Seeking Alpha
- 4 weeks ago - BioLineRx Reports Second Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates - PRNewsWire
- 4 weeks ago - biolinerx Q2 Earnings Preview - Seeking Alpha
- 5 weeks ago - BioLineRx to Report Second Quarter 2024 Results on August 15, 2024 - PRNewsWire
- 3 months ago - BioLineRx Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD) - PRNewsWire
- 3 months ago - BioLineRx Ltd. (BLRX) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioLineRx Reports First Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates - PRNewsWire